BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Authors
Keywords
HCC, survival, BCLC, ablation, surgery, liver transplantation TACE, TARE, systemic treatment, ALBI score, AFP
Journal
JOURNAL OF HEPATOLOGY
Volume 76, Issue 3, Pages 681-693
Publisher
Elsevier BV
Online
2021-11-19
DOI
10.1016/j.jhep.2021.11.018
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.
- (2022) Ghassan K. Abou-Alfa et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study.
- (2022) Shukui Qin et al. JOURNAL OF CLINICAL ONCOLOGY
- International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
- (2021) Amit G. Singal et al. GASTROENTEROLOGY
- End-points in clinical trials for liver cancer and their value in evidence based clinical decision making: an unresolved Gordian knot.
- (2021) Jordi Bruix JOURNAL OF HEPATOLOGY
- Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable Hepatocellular Carcinoma: The LEGACY Study
- (2021) Riad Salem et al. HEPATOLOGY
- MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era
- (2021) W. Ray Kim et al. GASTROENTEROLOGY
- Limited tumour progression beyond Milan criteria while on the waiting list does not result in unacceptable impairment of survival
- (2021) Joana Ferrer-Fàbrega et al. JOURNAL OF HEPATOLOGY
- Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis of local control, survival and toxicity outcomes
- (2021) Mihir D. Shanker et al. Journal of Medical Imaging and Radiation Oncology
- Systemic treatment of hepatocellular carcinoma: An EASL position paper
- (2021) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Methods of Public Health Research — Strengthening Causal Inference from Observational Data
- (2021) Miguel A. Hernán NEW ENGLAND JOURNAL OF MEDICINE
- The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
- (2020) Manuel de la Torre-Aláez et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis
- (2020) Marta Tonon et al. Clinical Gastroenterology and Hepatology
- Informative censoring — a neglected cause of bias in oncology trials
- (2020) Arnoud J. Templeton et al. Nature Reviews Clinical Oncology
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Local and Regional Therapies for Hepatocellular Carcinoma
- (2020) Roman Kloeckner et al. HEPATOLOGY
- Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
- (2020) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
- (2020) Neil Mehta et al. TRANSPLANTATION
- Expanding the Limits of Liver Transplantation for Hepatocellular Carcinoma
- (2020) Allison Kwong et al. Clinics in Liver Disease
- Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis.
- (2020) José Ferrusquía-Acosta et al. JOURNAL OF HEPATOLOGY
- Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma
- (2020) Jie Han et al. MEDICINE
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
- (2020) John D. Gordan et al. JOURNAL OF CLINICAL ONCOLOGY
- Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab
- (2020) Maria Reig et al. LIVER INTERNATIONAL
- Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients
- (2019) Adam Doyle et al. JOURNAL OF HEPATOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Liver Resection for Multiple Hepatocellular Carcinomas
- (2019) Yasuyuki Fukami et al. ANNALS OF SURGERY
- A multicenter randomized controlled trial to evaluate the efficacy of surgery vs. radiofrequency ablation for small hepatocellular carcinoma (SURF trial).
- (2019) Namiki Izumi et al. JOURNAL OF CLINICAL ONCOLOGY
- The prognostic role of hepatic venous pressure gradient in cirrhotic patients undergoing elective extrahepatic surgery
- (2019) Enric Reverter et al. JOURNAL OF HEPATOLOGY
- Development of a nomogram to predict outcome after liver resection for hepatocellular carcinoma in child-pugh b cirrhosis
- (2019) Giammauro Berardi et al. JOURNAL OF HEPATOLOGY
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
- (2019) Jens Ricke et al. JOURNAL OF HEPATOLOGY
- Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
- (2019) Richard S. Finn et al. JOURNAL OF CLINICAL ONCOLOGY
- Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
- (2018) Vincenzo Mazzaferro et al. GASTROENTEROLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical states of cirrhosis and competing risks
- (2018) Gennaro D'Amico et al. JOURNAL OF HEPATOLOGY
- Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
- (2018) Richard S. Finn et al. JOURNAL OF HEPATOLOGY
- Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
- (2018) Jean-Charles Nault et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study
- (2018) Lorenza Rimassa et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- OUP accepted manuscript
- (2018) ANNALS OF ONCOLOGY
- Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
- (2018) Roser Pinyol et al. GUT
- Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
- (2018) Anthony W.H. Chan et al. JOURNAL OF HEPATOLOGY
- Meta-analysis of short- and long-term outcomes after pure laparoscopic versus open liver surgery in hepatocellular carcinoma patients
- (2018) Jan Witowski et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
- (2018) Jean-Luc Raoul et al. CANCER TREATMENT REVIEWS
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
- (2017) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma
- (2017) David J. Pinato et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study
- (2017) Víctor Molina et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Comparative Short-term Benefits of Laparoscopic Liver Resection
- (2016) Ruben Ciria et al. ANNALS OF SURGERY
- Propensity score analysis of outcomes following laparoscopic or open liver resection for hepatocellular carcinoma
- (2016) C. Sposito et al. BRITISH JOURNAL OF SURGERY
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
- (2016) Jordi Bruix et al. GASTROENTEROLOGY
- Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial
- (2016) Jie Yu et al. GUT
- Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection
- (2016) Joana Ferrer-Fàbrega et al. HEPATOLOGY
- Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
- (2016) Karen T. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- The Primary Outcome Is Positive — Is That Good Enough?
- (2016) Stuart J. Pocock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hierarchic Interaction of Factors Associated With Liver Decompensation After Resection for Hepatocellular Carcinoma
- (2016) Davide Citterio et al. JAMA Surgery
- Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials
- (2016) Antonio Facciorusso et al. United European Gastroenterology Journal
- When to perform hepatic resection for intermediate-stage hepatocellular carcinoma
- (2015) Alessandro Cucchetti et al. HEPATOLOGY
- Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
- (2015) Francis Y. Yao et al. HEPATOLOGY
- Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation
- (2015) Christian Toso et al. HEPATOLOGY
- Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib
- (2015) Massimo Iavarone et al. HEPATOLOGY
- Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis
- (2015) Annalisa Berzigotti et al. HEPATOLOGY
- Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
- (2015) Philip J. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Can we expand the indications for laparoscopic liver resection? A systematic review and meta-analysis of laparoscopic liver resection for patients with hepatocellular carcinoma and chronic liver disease
- (2015) Zenichi Morise et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study
- (2015) Alessandro Vitale et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
- (2014) R Golfieri et al. BRITISH JOURNAL OF CANCER
- Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria
- (2014) Bilal Hameed et al. LIVER TRANSPLANTATION
- Treatment of intermediate-stage hepatocellular carcinoma
- (2014) Alejandro Forner et al. Nature Reviews Clinical Oncology
- A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
- (2013) T Meyer et al. BRITISH JOURNAL OF CANCER
- Postprogression survival of patients with advanced hepatocellular carcinoma: Rationale for second-line trial design
- (2013) Maria Reig et al. HEPATOLOGY
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma
- (2013) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ⩽3cm. Results of a multicenter Italian survey
- (2013) Maurizio Pompili et al. JOURNAL OF HEPATOLOGY
- Radiation lobectomy: Time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection
- (2013) Michael Vouche et al. JOURNAL OF HEPATOLOGY
- Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria
- (2012) Christophe Duvoux et al. GASTROENTEROLOGY
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
- (2012) Kai Feng et al. JOURNAL OF HEPATOLOGY
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
- (2012) Marta Burrel et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: An intention-to-treat analysis
- (2011) David Fuks et al. HEPATOLOGY
- Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques
- (2011) Jordi Bruix et al. HEPATOLOGY
- Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation
- (2011) Bruno Sangro et al. HEPATOLOGY
- Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival
- (2010) Philip Hilgard et al. HEPATOLOGY
- Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
- (2010) Giacomo Germani et al. JOURNAL OF HEPATOLOGY
- Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
- (2010) Alejandro Forner et al. SEMINARS IN LIVER DISEASE
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Multifaceted perspective of the waiting list for liver transplantation: The value of pharmacokinetic models
- (2009) Miquel Navasa et al. HEPATOLOGY
- Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis
- (2009) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: A Markov model analysis
- (2009) Yun Ku Cho et al. HEPATOLOGY
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis
- (2009) Gisèle N'Kontchou et al. HEPATOLOGY
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
- (2008) Vincenzo Mazzaferro et al. LANCET ONCOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Liver transplantation in patients with hepatocellular carcinoma across Milan criteria
- (2008) J. Ignacio Herrero et al. LIVER TRANSPLANTATION
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
- (2008) W. Ray Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started